Philips and Masimo Renew Strategic Partnership to Advance Next-Generation Patient Monitoring

Philips and Masimo Renew Strategic Partnership to Advance Next-Generation Patient Monitoring

By, Admin 15 September 2025

Royal Philips and Masimo have renewed their multi-year strategic collaboration, deepening their long-standing partnership to accelerate the delivery of next-generation patient monitoring solutions. The expanded agreement underscores both companies’ commitment to innovation, interoperability, and improved clinical outcomes across the continuum of care.

Partnership Highlights

  • Integration of Masimo technologies:
    -     SET® pulse oximetry
    - Radius PPG®
    - A portfolio of advanced sensor technologies
  • Embedded into Philips’ multi-parameter monitoring platforms including:
    - Bedside monitors
    - Central stations
    - Wearable solutions

This unified ecosystem gives clinicians reliable, actionable insights and the flexibility to use their preferred measurement technologies within a single system.

Next-Generation Monitoring Development

Beyond integration, Philips and Masimo will:

  • Co-develop and co-promote new monitoring solutions addressing emerging needs such as:
    - Greater patient mobility
    - Advanced wearables
    - AI-driven algorithms for predictive insights
  • Focus on smart, connected care that scales with evolving clinical and operational demands.

Leadership Perspectives

  • Julia Strandberg, EVP & Business Leader, Connected Care at Philips:

“This partnership allows us to respond quickly to evolving clinical needs and market trends, integrating proven technologies into solutions that are easy to use, reliable, and scalable.”

  • Katie Szyman, CEO of Masimo:

“Expanding our strong, long-standing partnership with Philips allows us to bring Masimo’s best-in-class technologies to more patients and empower clinicians to transform patient care.”

Why It Matters

  • Enhanced interoperability: Simplifies workflows and reduces system complexity.
  • Smarter decision-making: Delivers timely insights across care settings.
  • Scalability: Solutions designed to support both hospitals and home care.
  • Aligned strategies: Fits Philips’ broader goal of vendor-neutral interoperability and Masimo’s mission to expand noninvasive monitoring innovation.

About the Companies

  • Royal Philips: A global leader in health technology, focused on improving health and well-being through innovation in both consumer and professional healthcare solutions.
  • Masimo: A pioneer in advanced noninvasive monitoring technologies, including pulse oximetry, sensors, wearables, and AI-driven solutions.

This renewed alliance combines Philips’ strengths in patient monitoring with Masimo’s cutting-edge sensor and wearable technologies, positioning both companies to drive the next wave of clinically validated, connected care solutions worldwide.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!